Key result
Total hip replacement with dextran prophylaxis resulted in asymptomatic deep vein thrombosis in 33.9% (21 of 62) of patients on postoperative day 2, with many thrombi dissolving by day 9.
Why the study?
What is the incidence and natural history of deep vein thrombosis after total hip replacement in patients receiving dextran thromboprophylaxis?
Population
62 consecutive patients under dextran thromboprophylaxis after total hip replacement
Design
Cohort
Follow-up
9 days
Authors
Loading...
Early postoperative DVT screening may detect transient thrombi; leaves open optimal timing for imaging in hip replacement prophylaxis studies.
Cohort (n=62)
What is the incidence and natural history of deep vein thrombosis after total hip replacement in patients receiving dextran thromboprophylaxis?
Asymptomatic distal DVTs are common immediately after total hip replacement but frequently dissolve spontaneously within the first postoperative week, highlighting the importance of screening timing.
Høgevold et al. (1990) conducted a cohort in Deep vein thrombosis (n=62). Total hip replacement with dextran thromboprophylaxis was evaluated on Incidence of deep vein thrombosis on the second postoperative day. Total hip replacement with dextran prophylaxis resulted in asymptomatic deep vein thrombosis in 33.9% (21 of 62) of patients on postoperative day 2, with many thrombi dissolving by day 9.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: